Seller record · Telehealth service
PCOS Sisters
Fails 3 of 8 criteria. S4, compounding disclosure: The GLP-1 page offers semaglutide and other GLP-1 medications, microdosing and oral GLP-1 options without saying whether they are compounded or brand-name, and no page carries a statement about FDA approval. 2 more criteria also fail; see the table below.
At a glance
PCOS SistersTelehealth service
- Price
- GLP-1 care within the membership from $150 a month; a single evaluation visit $75
- Sells
- semaglutide, other GLP-1 medications, oral GLP-1 options, and 1 more
- FDA letters
- None on file
Telehealth service. Passes 5 of 8 criteria. Recorded against Standard v1.1.
A nurse-practitioner telehealth practice for women with PCOS, serving 11 states, that prescribes semaglutide and other GLP-1 medications, including microdosing and oral options, only within its paid membership. Visits are paid when booked, medication is billed by the pharmacy, and its footer names two partner pharmacies.
Operating entity The footer, the terms and conditions and the HIPAA privacy policy name the practice only as PCOS Sisters Telehealth Clinic & Wellness Center, with no company name such as an LLC or PLLC.
Dispositions
| Code | Criterion | Disposition | Where it appears |
|---|---|---|---|
| S1 | Prescriber requirement | PASS | PCOS Sisters' website; PCOS Sisters' how it works page; PCOS Sisters' GLP-1 management for page |
| S2 | Prescription gating | PASS | PCOS Sisters' how it works page; PCOS Sisters' terms and conditions |
| S3 | Pharmacy identification | PASS | PCOS Sisters' contact page; PCOS Sisters' members page |
| S4 | Compounding disclosure | FAIL | PCOS Sisters' GLP-1 management for page; PCOS Sisters' obesity and weight loss page; PCOS Sisters' how it works page |
| S5 | Analytical documentation | FAIL | PCOS Sisters' GLP-1 management for page; PCOS Sisters' FAQ; PCOS Sisters' terms and conditions |
| S6 | Business address | FAIL | PCOS Sisters' contact page; PCOS Sisters' HIPAA privacy policy |
| S7 | Price disclosure | PASS | PCOS Sisters' GLP-1 management for page; PCOS Sisters' how it works page |
| S8 | Enforcement status | PASS | FDA warning-letter index |
Evidence, criterion by criterion
The evidence behind each disposition in the table above, where it appears, and its date.
Products shown on the seller's own pages at the recorded date: semaglutide, other GLP-1 medications, oral GLP-1 options, GLP-1 microdosing.
Other sellers of the same products
Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.